Dipna Pharmachem Ltd Intrinsic Value
DPL · Healthcare · Current price ₹5.51
Is Dipna Pharmachem Ltd undervalued?
DocStoX estimates the fair value of Dipna Pharmachem Ltd at ₹18 per share, versus the current market price of ₹6. That puts the stock about +228.4% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹21), Relative P/E (₹14), Graham floor (₹15). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹14 (bear) to ₹18 (base) to ₹21 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹6 versus an intrinsic value of ₹18, Dipna Pharmachem Ltd currently offers +228.4% of margin.
More on Dipna Pharmachem Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.